Showing codes J9271 (Injection, pembrolizumab, 1 mg) — J9311 (Injection, rituximab 10 mg and hyaluronidase)

J9271 - Inj pembrolizumab
Long description: Injection, pembrolizumab, 1 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9272 - Inj, dostarlimab-gxly, 10 mg
Long description: Injection, dostarlimab-gxly, 10 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9273 - Inj tisotu vedotin-tftv, 1mg
Long description: Injection, tisotumab vedotin-tftv, 1 mg
Code added date: 20220401.
Code effective date: 20220401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9274 - Inj, tebentafusp-tebn, 1 mcg
Long description: Injection, tebentafusp-tebn, 1 microgram
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9275 - Inj cosibelimab-ipdl, 2 mg
Long description: Injection, cosibelimab-ipdl, 2 mg
Code added date: 20250701.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9276 - Inj zanidatamab-hrii, 2 mg
Long description: Injection, zanidatamab-hrii, 2 mg
Code added date: 20250701.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9280 - Mitomycin injection
Long description: Injection, mitomycin, 5 mg
Code added date: 19860101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9281 - Mitomycin instillation
Long description: Mitomycin pyelocalyceal instillation, 1 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9285 - Inj, olaratumab, 10 mg
Long description: Injection, olaratumab, 10 mg
Code added date: 20180101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9286 - Inj glofitamab gxbm, 2.5 mg
Long description: Injection, glofitamab-gxbm, 2.5 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9289 - Inj nivolumab 2 mg hyaluron
Long description: Injection, nivolumab, 2 mg and hyaluronidase-nvhy
Code added date: 20250701.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9292 - Inj, pemetrexed dipotassium
Long description: Injection, pemetrexed dipotassium, 10 mg
Code added date: 20250101.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9293 - Mitoxantrone hydrochl / 5 mg
Long description: Injection, mitoxantrone hydrochloride, per 5 mg
Code added date: 19900101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9294 - Inj pemetrexed, hospira 10mg
Long description: Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
Code added date: 20230401.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9295 - Injection, necitumumab, 1 mg
Long description: Injection, necitumumab, 1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9296 - Inj pemetrexed (accord) 10mg
Long description: Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
Code added date: 20230401.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9297 - Inj pemetrexed (sandoz) 10mg
Long description: Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
Code added date: 20230401.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9298 - Inj nivol relatlimab 3mg/1mg
Long description: Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9299 - Injection, nivolumab
Long description: Injection, nivolumab, 1 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9300 - Gemtuzumab ozogamicin inj
Long description: Injection, gemtuzumab ozogamicin, 5 mg
Code added date: 20020101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9301 - Obinutuzumab inj
Long description: Injection, obinutuzumab, 10 mg
Code added date: 20150101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9302 - Ofatumumab injection
Long description: Injection, ofatumumab, 10 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9303 - Panitumumab injection
Long description: Injection, panitumumab, 10 mg
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9304 - Inj. pemetrexed, 10 mg
Long description: Injection, pemetrexed (pemfexy), 10 mg
Code added date: 20201001.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9305 - Inj. pemetrexed nos 10mg
Long description: Injection, pemetrexed, not otherwise specified, 10 mg
Code added date: 20050101.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9306 - Injection, pertuzumab, 1 mg
Long description: Injection, pertuzumab, 1 mg
Code added date: 20140101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9307 - Pralatrexate injection
Long description: Injection, pralatrexate, 1 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9308 - Injection, ramucirumab
Long description: Injection, ramucirumab, 5 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9309 - Inj, polatuzumab vedotin 1mg
Long description: Injection, polatuzumab vedotin-piiq, 1 mg
Code added date: 20200101.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9310 - Rituximab injection
Long description: Injection, rituximab, 100 mg
Code added date: 19990101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9311 - Inj rituximab, hyaluronidase
Long description: Injection, rituximab 10 mg and hyaluronidase
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF